Meeker David P — SEC insider filings
SEC reporting owner CIK 1385155. 23 insider filings on record with FilingPulse; latest filed 2026-09-14.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2020-11-19 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $201,713 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 12 legs across 7 filings — 162,204 shares, $10,785,400 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 30,746 shares @ $102.35 ($3,146,761) in RHYTHM PHARMACEUTICALS, INC., filed 2026-09-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO, Director | 13 | 1 leg · 10,000 sh · $201,713 | 11 legs · 157,649 sh · $10,772,047 | 26 |
| Trevi Therapeutics, Inc. (TRVI) | Director | 8 | — | 1 leg · 4,555 sh · $13,353 | 9 |
| MyoKardia, Inc. (MYOK) | Director | 1 | — | — | 6 |
| Kardigan, Inc. (KARD) | Director | 1 | — | — | 1 |
Insider filings — Meeker David P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 50,000 @ $6.05 · Sale (S): 6,439 @ $101.75 · Sale (S): 30,746 @ $102.35 · Sale (S): 8,698 @ $103.43 · Sale (S): 1,817 @ $104.55 · Sale (S): 2,300 @ $105.19 · +1 more | EDGAR |
| 2026-06-22 | 4 | Kardigan, Inc. (KARD) | Grant/award (A): 20,706 @ $0 | EDGAR |
| 2026-06-04 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 71,900 (derivative) @ $0 · Grant/award (A): 107,850 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 68,713 · Tax withholding (F): 31,522 @ $108.99 · Option exercise (M): 14,125 (derivative) @ $0 · Option exercise (M): 21,250 (derivative) @ $0 · Option exercise (M): 33,338 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 43,620 @ $4.59 · Sale (S): 43,346 @ $65.04 · Sale (S): 274 @ $65.60 · Option exercise (M): 43,620 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 21,250 · Sale (S): 9,896 @ $57.22 · Grant/award (A): 133,350 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 · Option exercise (M): 21,250 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 14,125 · Sale (S): 4,278 @ $59.43 · Option exercise (M): 14,125 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 4,555 @ $1.43 · Sale (S): 4,555 @ $2.93 · Option exercise (M): 4,555 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 45,494 @ $39.22 | EDGAR |
| 2024-02-21 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 99,000 @ $0 · Grant/award (A): 85,000 (derivative) @ $0 · Grant/award (A): 259,000 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 14,125 · Sale (S): 4,361 @ $45.06 · Option exercise (M): 14,125 (derivative) @ $0 | EDGAR |
| 2023-06-30 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-02-03 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 56,500 (derivative) @ $0 · Grant/award (A): 229,600 (derivative) @ $0 | EDGAR |
| 2022-07-01 | 4/A | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-23 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-02-11 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 510,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Purchase (P): 10,000 @ $20.17 | EDGAR |
| 2021-02-16 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2020-11-19 | 4 | MyoKardia, Inc. (MYOK) | Code (U): 4,100 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1385155 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs